IP Library Granted Patent US 9,725,478
Granted Patent B2
US 9,725,478 · App. 14/946,137 · Granted Aug 8, 2017

Process for the preparation of benzylbenzene SGLT2 inhibitors

Inventors: Baihua Xu (Malden, MA); Binhua Lv (Shanghai, CN); Ge Xu (Shanghai, CN); Brian Seed (Boston, MA); Jacques Roberge (Princeton, NJ)
Assignee: Theracos Sub, LLC
C07H7/04C07C37/00C07C37/16C07C41/01C07C41/16C07D309/10C07H15/04C07H23/00C07C2101/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,478
App. No.
14/946,137
Granted
Aug 8, 2017
Kind
B2
Abstract

Provided are methods of making compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides synthetic intermediates useful for preparing such compounds.

Claims (31)

1. A composition comprising

a compound of formula Ia having the structure:

 in an amount of at least 95% of the composition,

side-product A having the structure:

 in an amount of less than about 1% of the composition, and

side-product B having the structure:

 in an amount of less than about 3% of the composition,

wherein the composition is prepared by the method comprising:

(a) forming a first reaction mixture comprising a compound of Formula IIa:

an alkyl-magnesium complex selected from the group consisting of C 1 -C 4 alkylmagnesium chloride, C 1 -C 4 alkylmagnesium bromide, di(C 1 -C 4 alkyl)magnesium, C 3 -C 7 cycloalkylmagnesium chloride, C 3 -C 7 cycloalkylmagnesium bromide, and di(C 3 -C 7 cycloalkyl)magnesium, and

a first organic solvent,

wherein the ratio of the alkyl-magnesium complex to the compound of Formula IIa is less than or equal to 1.0 (mol/mol), and

wherein the first reaction mixture is at a temperature of less than about −50° C., to afford ara intermediate compound,

(b) forming a second reaction mixture comprising the intermediate compound, a second organic solvent, and a compound of Formula IIIa:

 to afford the compound of Formula Ia wherein R 4 is OH,

(c) forming a third reaction mixture comprising a C 1 -C 3 alkylhydroxy, a strong acid and the compound of Formula Ia wherein R 4 is OH, thereby forming the compound of Formula Ia wherein R 4 is C 1 -C 3 alkoxy; and

(d) forming a fourth reaction mixture comprising a reducing agent and the compound of Formula Ia wherein R 4 is C 1 -C 3 alkoxy, thereby preparing the compound of Formula Ia wherein R 4 is H, and

wherein

X is iodo,

R 1 is chloro,

R 2 is H,

R 3 is (C 3 -C 6 cycloalkoxy)C 1 -C 3 alkoxy,

R 4 is selected from the group consisting of H, OH and C 1 -C 3 alkoxy, and

R b is a protecting group.

2. The composition of claim 1 , comprising

the compound of formula Ia having the structure:

 in an amount of at least 95% of the composition,

side-product A having the structure:

 in an amount of less than about 1% of the composition, and

side-product B having the structure:

 in an amount of less than about 3% of the composition.

Assignments (3)
CHANGE OF NAME Recorded Jan 10, 2023
From: THERACOS SUB, LLC
To: THERACOSBIO, LLC
Reel/Frame 062351/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2017
From: XU, BAIHUA; LV, BINHUA; XU, GE; SEED, BRIAN; ROBERGE, JACQUES Y.
To: THERACOS, INC.
Reel/Frame 041546/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2017
From: THERACOS, INC.
To: THERACOS SUB, LLC
Reel/Frame 041546/0121 →
Priority Claims (1)
WO PCT/CN2012/073697 · Apr 10, 2012 · international
Continuity (3)
Division 13889980 · May 8, 2013
Continuation PCTCN2013072642 · Mar 14, 2013
Related Publication 20160207952A1 · Jul 21, 2016